General
Preferred name
CHLOROTHIAZIDE
Synonyms
NSC-25693 ()
Hydrochlorothiazide impurity, chlorothiazide- ()
Clorotiazida ()
Diuril ()
Saluric ()
Chlorothiazide sodium salt ()
CHLOROTHIAZIDE SODIUM ()
P&D ID
PD002427
CAS
58-94-6
7085-44-1
Tags
available
drug
Approved by
FDA
First approval
1958
Drug indication
Hypertension
Congestive heart failure
Drug Status
approved
investigational
vet_approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Chlorothiazide is an orally active diuretic and anti-hypertensive agent[1].
DESCRIPTION
Chlorothiazide is a first-in-class thiazide diuretic initially discovered from its ability to inhibit carbonic anhydrase. Chlorothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.
(Enamine Bioactive Compounds)
DESCRIPTION
Carbonic anhydrase inhibitor; diuretic; antihypertensive
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
29
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
LOPAC library
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
75
Molecular Weight
294.95
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
1
Ring Count
2
Aromatic Ring Count
1
cLogP
-0.06
TPSA
118.69
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.75
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
Carbonic anhydrase
Member status
virtual
MOA
SLC12A3 inhibitor
CA1 inhibitor
CA2 inhibitor
CA4 inhibitor
diuretic
Indication
hypertension
Target
CA1, CA2, CA4, SLC12A3
Renin
Therapeutic Class
Antihypertensive Agents
Pathway
Metabolic Enzyme/Protease
Source data

